UA90656C2 - Габоксадол для лечения депрессии - Google Patents

Габоксадол для лечения депрессии

Info

Publication number
UA90656C2
UA90656C2 UAA200600374A UAA200600374A UA90656C2 UA 90656 C2 UA90656 C2 UA 90656C2 UA A200600374 A UAA200600374 A UA A200600374A UA A200600374 A UAA200600374 A UA A200600374A UA 90656 C2 UA90656 C2 UA 90656C2
Authority
UA
Ukraine
Prior art keywords
gaboxadol
treating depression
pharmaceutical composition
relates
serotonin
Prior art date
Application number
UAA200600374A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Конни Санчес
Бьярке Эберт
Original Assignee
Х. Луннбек А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701616&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA90656(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Луннбек А/С filed Critical Х. Луннбек А/С
Publication of UA90656C2 publication Critical patent/UA90656C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200600374A 2003-06-25 2004-06-25 Габоксадол для лечения депрессии UA90656C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25

Publications (1)

Publication Number Publication Date
UA90656C2 true UA90656C2 (ru) 2010-05-25

Family

ID=36701616

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200600374A UA90656C2 (ru) 2003-06-25 2004-06-25 Габоксадол для лечения депрессии

Country Status (4)

Country Link
CN (2) CN101156850A (zh)
CL (1) CL2004001603A1 (zh)
UA (1) UA90656C2 (zh)
ZA (1) ZA200509356B (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816457A (zh) * 2016-05-30 2016-08-03 杨强 含有盐酸帕罗西汀的药物组合物及其用途
US20180338959A1 (en) * 2017-05-24 2018-11-29 Ovid Therapeutics Inc. Treatment of depressive disorders
CA3095682A1 (en) * 2018-04-06 2019-10-10 Ovid Therapeutics Inc. Use of gaboxadol in the treatment of substance use disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123332B2 (en) 2018-11-21 2021-09-21 Certego Therapeutics Inc. Gaboxadol for reducing risk of suicide and rapid relief of depression
US11597726B2 (en) 2020-05-20 2023-03-07 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
ZA200509356B (en) 2007-03-28
CL2004001603A1 (es) 2005-05-27
CN101156850A (zh) 2008-04-09
CN1809350A (zh) 2006-07-26

Similar Documents

Publication Publication Date Title
IL202106A0 (en) Gaboxadol for treating depression and other affective disorders
MY153915A (en) Organic compounds
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
MX2009005455A (es) (r)-n-estereoisomeros de analogos de 7,8-saturados-4,5 epoxi-morfinano.
WO2008021851A3 (en) Novel compounds as antagonists or inverse agonists for opioid receptors
TW201713640A (en) Bruton's tyrosine kinase inhibitors
TW200740799A (en) Alpha2C adrenoreceptor agonists
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
WO2008034142A3 (en) Synthesis, methods of using, and compositions of cycloalkylmethylamines
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
TW200942524A (en) Novel aminomethyl benzene derivatives
TW200736227A (en) New compounds III
TW200700071A (en) Novel use
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
TNSN07241A1 (en) Substituted pyrroles, compositions containing same, method for making same and use thereof
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
UA90656C2 (ru) Габоксадол для лечения депрессии
UA92180C2 (en) Benzimidazole thiophene compounds as plk inhibitors
MEP1908A (xx) Gabaksadol za liječenje depresije i drugih afektivnih poremećaja
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
TW200706173A (en) Oral composition comprising carbamylating agent